Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Carcinoma, Non-Small-Cell Lung × tremelimumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 12 INDUSTRY 8 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrent Squamous Cell Lung Carcinoma 2 Prostatic Neoplasms 2 Colorectal Neoplasms 2 Squamous Non-small Cell Lung Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Malignancies 1 Neoplasms 1 Lung Cancer Metastatic 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Advanced Rare Tumours 1

Interventions

Carboplatin 31 Paclitaxel 26 Cisplatin 22 Radiotherapy 21 Docetaxel 16 Gemcitabine 12 Pemetrexed 11 Radiosurgery 9 Bevacizumab 8 Etoposide 7 Magnetic Resonance Spectroscopy 6 Erlotinib Hydrochloride 6 Gene Expression Profiling 5 Cetuximab 5 durvalumab 4 cediranib 4 Vinorelbine 4 Specimen Handling 4 Ramucirumab 4 Polymerase Chain Reaction 4 Amplified Fragment Length Polymorphism Analysis 4 Watchful Waiting 3 Taxes 3 Surgical Procedures, Operative 3 Radiotherapy, Conformal 3 Psychiatric Rehabilitation 3 Neoadjuvant Therapy 3 Chemotherapy, Adjuvant 3 sotorasib 2 selpercatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03965468 2026-02-09

CHESS

ETOP IBCSG Partners Foundation

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡